The Short-Term Efficacy of Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema
Journal of the Korean Ophthalmological Society
; : 1453-1458, 2010.
Article
em Ko
| WPRIM
| ID: wpr-100163
Biblioteca responsável:
WPRO
ABSTRACT
PURPOSE: To evaluate the short-term effect of an intravitreal injection of ranibizumab in the treatment of diabetic macular edema. METHODS: Eighteen eyes of 18 patients who underwent intravitreal ranibizumab injection for the treatment of diabetic macular edema between March 1 and November 30, 2009 were retrospectively evaluated. Complete ophthalmic examinations including best corrected visual acuity and optical coherence tomography (OCT) were performed at baseline and follow-up visits at one and three months. RESULTS: The mean Visual Acuity Improved From Logmar 0.74 +/- 0.45 At Baseline To Logmar 0.44 +/- 0.26 At One Month And To Logmar 0.42 +/- 0.23 At Three Months (P < 0.05). The Mean Central Macular Thickness Decreased From 429.5 +/- 71.9 microM At Baseline To 299.9 +/- 81.2 microM At One Month And To 284.6 +/- 82.6 microM At Three Months (P < 0.05). No Adverse Side Effects Were Observed Following the injections. CONCLUSIONS: The observed macular edema and visual acuity improvements demonstrated that intravitreal ranibizumab injection may be useful for the treatment of patients with diabetic macular edema.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Acuidade Visual
/
Edema Macular
/
Estudos Retrospectivos
/
Seguimentos
/
Tomografia de Coerência Óptica
/
Olho
/
Injeções Intravítreas
/
Anticorpos Monoclonais Humanizados
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
Ko
Revista:
Journal of the Korean Ophthalmological Society
Ano de publicação:
2010
Tipo de documento:
Article